TFPI Antibody (befovacimab) [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28491DL594
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Flow Cytometry, Functional
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Recombinant Monoclonal Human IgG2 Clone # befovacimab
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for TFPI Antibody (befovacimab) [DyLight 594]
Immunogen
TFPI
Clonality
Monoclonal
Host
Human
Isotype
IgG2
Applications for TFPI Antibody (befovacimab) [DyLight 594]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: TFPI
Long Name
Tissue Factor Pathway Inhibitor
Alternate Names
EPI, LACI
Gene Symbol
TFPI
Additional TFPI Products
Product Documents for TFPI Antibody (befovacimab) [DyLight 594]
Product Specific Notices for TFPI Antibody (befovacimab) [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...